The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And the thinking there is that, well, if you can find compounds that work in not only different labs to the same extent, but also at different genetic backgrounds, then you've maybe got a high value candidate to then take forward into more expensive mouse study.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
We do. We are able to find reproducible and robust compounds that work in lots of different genetic backgrounds and extend lifespan in all three labs.